Pharmaceutical Industry How Does the Term Paper

Download this Term Paper in word format (.doc)

Note: Sample below may appear distorted but all corresponding word document files contain proper formatting

Excerpt from Term Paper:

For example, before its paten ran out, "the price of Schering-Plough's top-selling allergy pill, Claritin, was raised thirteen times over fives years, for a cumulative increase of more than 50%, over four times the rate of general inflation." In 2002, the average price of the fifty drugs most used by senior citizens was approximately $1,500 for a year's supply, and although this refers to what the companies call the average wholesale prices, but is also roughly close to what an individual without insurance pays at the pharmacy.

The increase in research dollars and in GNP share contributed to the business cycle expansion as pharmaceutical firms increased their research and development and brought new drugs to market," says Michael Hood. For over two decades, the pharmaceutical industry has been by far the most profitable in the United States, but not particularly innovative, considering that only a few truly important drugs have been brought to market in recent years, and they were mostly based on taxpayer-funded research at academic institutions, small biotechnology companies or the National Institutes of Health. Moreover, the great majority of "new" drugs are actually just variations of older drugs that are already on the market. In fact, during the last twenty years or so, the pharmaceutical industry has moved from its original purpose of discovering and producing useful new drugs and is now primarily a marketing machine to sell drugs of dubious benefit. From 1960 to 1980, prescription drug sales were fairly static as a percent of U.S. gross domestic product, however from 1980 to 2000, they tripled, and today they stand at more than $200 billion a year. IMS Health estimated total worldwide sales for prescription drugs to be approximately $400 billion in 2002, and roughly half were in the United States.

Growth in the pharmaceutical sector shows pharmaceutical employment expanding at a greater rate than the economy, and according to a U.S. Department of Labor's Bureau of Labor Statistics report, between 1998 and 2008 jobs in the drug manufacturing industry, which does not include biotech research laboratories, will increase by some 11%, making it one of the fastest-growing manufacturing industries. Moreover, the report claims that "faster than average growth is expected for professional specialty occupations, especially the biological and medical scientists engaged in research and development, the backbone of the drug industry, and computer systems analysts, engineers, and scientists." The BLS report also revealed that nearly half, or some 46.4% of the workforce in drug manufacturing is employed by a few extremely large, meaning 25,000 or more employees, pharmaceutical companies.

Works Cited

Angell, Marcia. "The Truth About the Drug Companies." New York Review of Books:

Volume 51, Number 12. July 15, 2005. Retrieved October 24, 2005 at http://www.nybooks.com/articles/17244

Ault, Alicia. "Pharmaceutical industry: Still booming after all these years." The Black Collegian. February 2000. Retrieved October 24, 2005 at http://www.findarticles.com/p/articles/mi_qa3628/is_200002/ai_n8887858#continue

Felton, Michael J. "Pharmaceutical Job Market Still Growing and Glowing."

Modern Drug Discover. October 2000, Volume 3, No.8. Retrieved October 24, 2005 at http://pubs.acs.org/subscribe/journals/mdd/v03/i08/html/felton.html

King, Charles. "Marketing, Product Differentiation, and Competition in the Market for Antiulcer Drugs." December 18, 2000. Harvard Business School. Retrieved October 24, 2005 at http://hbswk.hbs.edu/item.jhtml?id=1850&t=marketing

Lehman, Deb. "Biotechnology: industry of the future: biotech grows worldwide; U.S.

A retains global leadership position." Plants Sites & Parks. March 01, 2003. Retrieved October 24, 2005 from HighBeam Research Library Web site.

Meyers, John H. "The U.S. retail prescription market year in review." Medical Marketing

Media. April 01, 1996. Retrieved October 24, 2005 from HighBeam Research Library Web site.

Pharmaceutical Industry Plays Big Role In American Economy. Retrieved October 24, 2005 at http://www.tamu.edu/univrel/aggiedaily/news/stories/04/082304-6.html

Trombetta, Bill. "Industry audit: for the fourth year in a row, Pharmaceutical Executive slices and dices the numbers to learn who's really on top." Pharmaceutical Executive. September 01, 2005. Retrieved October 24, 2005 from HighBeam Research Library Web site.

Trombetta, Bill. "Industry audit: for the fourth year in a row, Pharmaceutical Executive slices and dices the numbers to learn who's really on top." Pharmaceutical Executive. September 01, 2005

Meyers, John H. "The U.S. retail prescription market year in review." Medical Marketing

Media. April 01, 1996

Lehman, Deb. "Biotechnology: industry of the future: biotech grows worldwide; U.S.

A retains global leadership position." Plants Sites & Parks. March 01, 2003

King, Charles. "Marketing, Product Differentiation, and Competition in the Market for Antiulcer Drugs." December 18, 2000. Harvard Business School

Ault, Alicia. "Pharmaceutical industry: Still booming after all these years." The Black Collegian. February 2000

Angell, Marcia.…[continue]

Cite This Term Paper:

"Pharmaceutical Industry How Does The" (2005, October 25) Retrieved December 6, 2016, from http://www.paperdue.com/essay/pharmaceutical-industry-how-does-the-69775

"Pharmaceutical Industry How Does The" 25 October 2005. Web.6 December. 2016. <http://www.paperdue.com/essay/pharmaceutical-industry-how-does-the-69775>

"Pharmaceutical Industry How Does The", 25 October 2005, Accessed.6 December. 2016, http://www.paperdue.com/essay/pharmaceutical-industry-how-does-the-69775

Other Documents Pertaining To This Topic

  • Pharmaceuticals Industry Political and Social

    There are two constant irritations in U.S. pharma companies' relationships internationally: Some developing nations, such as India, Brazil and South Africa, are chipping away at the patent situation, trying to shorten the time until the drugs can be brought out in generic form. The U.S. has supported high prices as the cost for innovation. Since other countries are not playing along, this means that their citizens are benefiting from the innovation paid

  • Ethical Dilemma Faced by the Pharmaceutical Industry

    Pharmaceutical Ethics Issues Generally, business ethics is a concept that has not been upheld or exemplified to any high standard by the modern pharmaceutical industry. It is an industry frequently plagued by unethical marketing decisions and practices, the pursuit of business strategies and policies that violate public trust in spirit if not necessarily in the written word, and that has embraced research practices that are sometimes highly questionable. In the modern

  • US Health Care and Pharmaceutical Industry

    Sick: The Untold Story of America's Health Care Crisis -- and the People Who Pay the Price. Brief summary of the book, including strengths and weaknesses Jonathan Cohn's "The Untold Story of America's Health-Care Crisis and the People Who Pay the Price" provides a detailed account of challenges that exist within the current healthcare system. The book highlights true stories from five years of travel conducted by the author. During his travels,

  • Corporate Social Responsibility in Indian Pharmaceutical Industry

    Corporate Social Responsibility in Indian Pharmaceutical Industry An Exploratory Study Outlook of CSR in India History of CSR in India Philanthropy in Indian Society Modern Form of CSR in Indian Society Profile of Indian Pharmaceutical Industry Rationale for Selection CSR Activities by Indian Pharmaceutical Companies Major Influences Over CSR Activities Scope of CSR Activities Comparison of Indian & Western Pharmaceutical Companies This research paper is concerned with the recent practices of Indian pharmaceutical companies in the field of corporate social responsibility. For

  • Marketing Management While the Pharmaceutical Industry Generally

    Marketing Management While the pharmaceutical industry generally designs marketing campaigns to focus on customers, leaders in this sector must be able to set themselves apart from their competitors . In ideally achieving a leadership role in this industry, such a firm would likely have developed a strong sense of reliability and loyalty among its customers. Furthermore, as customers will directly interact with the final products, it becomes increasingly important for a

  • Pfizer the Economics of the Pharmaceutical Industry

    Pfizer The Economics of the Pharmaceutical Industry -- Focus on Pfizer Drugs Specify on some background of the company According to its official website, Pfizer Incorporated "discovers, develops, manufactures, and markets leading prescription medicines for humans and animals and many of the world's best-known consumer brands. Our innovative, value-added products improve the quality of life of people around the world and help them enjoy longer, healthier, and more productive lives. The company has

  • Pharmaceutical Companies Intellectual Property and the Global AIDS...

    Pharmaceutical Companies, Intellectual Property, and the Global AIDS Epidemic For this case study, six questions had been asked. The first one is: Should pharmaceutical companies distribute drugs at low cost in third world countries? What are the pros and cons of such an approach? The second one is: What are the principal arguments of pharma companies who oppose making exception to IPR laws for developing countries? What are the arguments by


Read Full Term Paper
Copyright 2016 . All Rights Reserved